INTIMATION FOR BODHIKA SEMINAR - 04/05/2022

DEPARTMENT  OF  KAYA CHIKITSA

GOVT. AYURVEDA COLLEGE, THIRUVANANTHAPURAM

NAME  OF  FIRST PRESENTEE: Dr SUJINA V S

THESIS TITLE: EFFECT OF NAVAKARSHIKA KWATHAM IN HYPERURICEMIA 

NAME OF GUIDE: Dr  K  AMBIKA 

NAME OF CO GUIDE: Dr PRAVITH N K

DATE:04/05/2022

TIME: 2:00-4:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Hyperuricemia is defined as a serum urate concentration of >6.8mg /dl for men and >5.7mg/dl for women. Worldwide, the prevalence of hyperuricemia has increased substantially in recent decades. The most well-known disease induced by hyperuricemia is gout. However, many studies have reported that   hyperuricemia also plays important roles in cardiac-kidney vascular system disease and metabolic syndrome. Hyperuricemia results from the increased production or impaired excretion of metabolic product of purine metabolism, uric acid4. Since it is an outcome of impaired uric acid metabolism, in Ayurveda this clinical entity can be correlated to Kapha- Pitta pradhana mala sanchaya in the level of rasa-rakta dhatu attributed by rasa –rakta dhatwagni mandhyam. The study drug Navakarshika kwatham described in Chakradutta Vatarakta chikitsa shloka no23-25 is widely used by Ayurvedic practitioners of kerala for treating hyperuricemia and its complications and is a unique combination of ama pachana, agni deepana, rakta prasadana, kapha-pittahara drugs. In this study clinical evaluation of hypouricemic effect of Navakarshika kwatham will be done as interventional study-pre and post Test without control group in 20 patients. The study setting is OPD of Kayachikitsa, Government Ayurveda College Hospital,Thiruvananthapuram. Patients in the age group of 30 -60 years, males having serum uric acid levels above 6.8mg/dl and females having serum uric acid levels above 5.7mg/dl will be included, drug Navakarshika kwatham administered for 30 days and clinical assessment will done by estimation of serum uric acid levels before and after the intervention.

NAME  OF  SECOND PRESENTEE: Dr SANDEEP KARUN

THESIS TITLE: EFFECT OF SWAYAMGUPTADI 

CHOORNA IN ERECTILE DYSFUNCTION

NAME OF GUIDE: Dr  SUNEESHMON M S

DATE:04/05/2022

TIME: 2:00-4:00 PM

VENUE: HYBRID / MICROSOFT TEAMS 

ABSTRACT

Erectile dysfunction has been defined as the disorder characterized by the persistent or recurrent inability to achieve or to maintain an erection during sexual activity. The male sexual dysfunctions include all sort of disturbance of coital performance and sexual congress in male.

The first line treatment of erectile dysfunction consists of a trial of Phosphodiesterase 5 (PDE5) Inhibitor drugs and are also associated with many serious complications including myocardial infarction, arrhythmias, hypotension etc. In order to find out a potential, cost effective and user-friendly compound with minimal side effects and to assess the effect of “swayamgupthadi choorna  ” in erectile dysfunction, this particular study was under taken.

In Ayurveda it can be compared to the concept of klaibya or dwajabanga. Multiple doshas are involved in the pathology of this condition, particularly with vyaana,apana and sukra dusti and dhatu shitilatha. Study will be a before and after study without control group conducted in Govt. Ayurveda College, Trivandrum. After conducting the necessary investigations and obtaining the baseline data as per the semi structured questionnaire, swayamgupthadi choorna  will be given to patients for one month. IIEF-5 questionnaire will be taken on 0^th day  of drug administration ,day after shodhana karma 1^st ,7^th ,14^th ,21^st  and 30^th  day of drug administration and 7^th day  follow up. Sample size is 20 ,  At present 16 participants registered and effect of therapy also assessed among them.